Nalox-1 Pharmaceuticals, LLC v. Opiant Pharmaceuticals, Inc.

Track this case

Case Number:

IPR2019-00685

Case Type:

IPR

Status:

Final Written Decision

Petitioner:

Nalox-1 Pharmaceuticals, LLC

Patent Owner:

Opiant Pharmaceuticals, Inc.

Patent Number:

9211253

Tech Center:

1600

  1. Filed: February 19, 2019 00:00

    Coverage

    1. August 24, 2020

      PTAB Upholds Entirety Of 3 Narcan Patents

      The Patent Trial and Appeal Board has refused to invalidate three different patents covering Adapt Pharma Ltd.'s opioid overdose treatment Narcan, two of which had a different fate in district court.

    1 other articles on this case. View all »

    Stay ahead of the curve

    In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


    • Search PTAB cases and full-text documents.
    • Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
    • Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!

    TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!